Characteristics of the current situation of drug use in elderly patients with chronic diseases in Chongqing: A cross-sectional survey

Xiaolei Hu,Min Tang,Jie Feng,Weiqiong Chen,Guangcan Li,Ling Ding,Mo Cheng,Mengying Liu,Jun Zhou,Xiaofei Liu,Jia Liu
DOI: https://doi.org/10.1097/md.0000000000040470
IF: 1.6
2024-11-28
Medicine
Abstract:Chronic diseases are the major public health concerns worldwide. Drugs are 1 of the important therapies for treating, preventing, and controlling chronic diseases. Over recent years, aging of the world's population has accelerated. The survey results of the National Bureau of Statistics of China have reported that the proportion of the population > 65 years old reaches 13.5% [ 1 ] and is expected to exceed 27.9% in 2050, [ 2 ] much higher than the world average estimate of 16%. [ 3 ] As a result, the elderly have become the most prevalent group affected by chronic diseases, and they usually suffer from 2 or more chronic diseases. About 45.2% of elderly patients with chronic diseases in the United States developed comorbidities is, [ 4 ] compared with 43.7% in China. [ 5 ] As drug combination therapy is the main modality to control symptoms of chronic diseases and even facilitate secondary prevention, and elderly patients with comorbidity often take multiple drugs. Simultaneous use of 5 or more kinds of drugs is known as polypharmacy.
medicine, general & internal
What problem does this paper attempt to address?